H istorically, medical research has been male-dominated in terms of subjects as well as researchers, even though women make up half of the world’s population. As a result of this gender bias, insights ...

This article delves into the potential connections between ED and hair loss, examining the roles of hormones, lifestyle, and ...

Amid feelings of patient neglect and medical uncertainty, women are finding solace and support in each other online.

Background The purpose of this study was to explore the budget impact of dutasteride plus tamsulosin fixed-dose combination (DUT + TAM FDC) versus tamsulosin monotherapy, in the treatment of ...

Many studies suggest that an earlier age at menopause is more detrimental to a woman's health, leading to an increased risk ...

Losing weight in menopause can help with the severity of other menopause symptoms like hot flashes and night sweats, ...

Dutasteride, which is marketed by GSK as Avodart ... is the main cause of hair loss in men but affects both men and women. According to GlobalData, there are 49 drugs in development for the ...

The most common form of hair loss in men and women, Pattern Hair Loss, is driven by hormones, specifically an inherited sensitivity to a build-up of DHT in follicles. Both the male-only prescription ...

Women typically see hair loss related to hair products more ... Alpha-reductase inhibitors, such as Propecia (finasteride) and Avodart (dutasteride), are additional options for male pattern hair loss.

Some Democratic lawmakers warn that in addition to further rollbacks of women’s reproductive rights, a second Donald Trump presidency would also mean a reversal of the progress that has been made in ...

The European Medicines Agency is reviewing the drugs finasteride and dutasteride to decide whether their authorizations should be withdrawn, varied, suspended or maintained in the European market.

The aim of this study was to assess the budget impact of the fixed dose combination dutasteride and tamsulosin (DUT + TAM FDC) versus tamsulosin monotherapy for the treatment of moderate to ...